Showing results (1381-1390 of 1,447) with videos related to
Sort By:
Pageof 145
Proteomics. Clinical Applications|March 11, 2014
Application of proteomics in the study of rodent models of cancerMikkel G Terp, Henrik J DitzelProteomics. Clinical Applications|March 5, 2014
Aminopeptidase activities as prospective urinary biomarkers for bladder cancerJennifer M Taylor, Mariana Yaneva, Kevin Velasco, et al.Proteomics. Clinical Applications|March 5, 2014
Model organism proteomics as a tool for the study of host-microbiome interactionsLiam Cassidy, Andreas TholeyProteomics. Clinical Applications|February 20, 2014
The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathyRichard D Semba, Hu Huang, Gerard A Lutty, et al.Proteomics. Clinical Applications|February 4, 2014
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosisCindy Salvisberg, Nadja Tajouri, Alexandre Hainard, et al.Proteomics. Clinical Applications|February 19, 2014
Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancerRuth Anna Fuhrman-Luck, Munasinghage Lakmali Silva, Ying Dong, et al.Proteomics. Clinical Applications|October 28, 2018
Translating N-Glycan Analytical Applications into Clinical Strategies for Ovarian CancerMatthew T Briggs, Mark R Condina, Manuela Klingler-Hoffmann, et al.Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.Proteomics. Clinical Applications|November 1, 2012
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challengeQing Kay Li, Ed Gabrielson, Frederic Askin, et al.Proteomics. Clinical Applications|November 1, 2012
Considerations on selected reaction monitoring experiments: implications for the selectivity and accuracy of measurementsBruno DomonPageof 145